Business Description
Newron Pharmaceuticals SpA
NAICS : 325412
ISIN : IT0004147952
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | -1.16 | |||||
Debt-to-Equity | -1.62 | |||||
Debt-to-EBITDA | -4.04 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.3 | |||||
Beneish M-Score | -3.63 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.6 | |||||
3-Year EBITDA Growth Rate | 15.6 | |||||
3-Year EPS without NRI Growth Rate | 12.4 | |||||
3-Year FCF Growth Rate | 17.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 75.3 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.9 | |||||
9-Day RSI | 40.04 | |||||
14-Day RSI | 41.59 | |||||
6-1 Month Momentum % | 63.16 | |||||
12-1 Month Momentum % | 60.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.68 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.44 | |||||
Days Sales Outstanding | 80.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.35 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -127.39 | |||||
Net Margin % | -178.07 | |||||
FCF Margin % | -111.89 | |||||
ROA % | -50.73 | |||||
ROIC % | -53.62 | |||||
ROC (Joel Greenblatt) % | -820.95 | |||||
ROCE % | -79.88 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 10.72 | |||||
PS Ratio | 14.71 | |||||
EV-to-EBIT | -14.37 | |||||
EV-to-Forward-EBIT | 5.14 | |||||
EV-to-EBITDA | -14.62 | |||||
EV-to-Forward-EBITDA | 5.14 | |||||
EV-to-Revenue | 18.97 | |||||
EV-to-Forward-Revenue | 4.5 | |||||
EV-to-FCF | -16.84 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
Earnings Yield (Greenblatt) % | -6.95 | |||||
FCF Yield % | -7.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Newron Pharmaceuticals SpA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 8.719 | ||
EPS (TTM) (CHF) | -0.87 | ||
Beta | 0.72 | ||
Volatility % | 86.16 | ||
14-Day RSI | 41.59 | ||
14-Day ATR (CHF) | 0.507028 | ||
20-Day SMA (CHF) | 7.529 | ||
12-1 Month Momentum % | 60.69 | ||
52-Week Range (CHF) | 3.7 - 10.8 | ||
Shares Outstanding (Mil) | 18.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Newron Pharmaceuticals SpA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Newron Pharmaceuticals SpA Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Newron Pharmaceuticals SpA Frequently Asked Questions
What is Newron Pharmaceuticals SpA(XSWX:NWRN)'s stock price today?
When is next earnings date of Newron Pharmaceuticals SpA(XSWX:NWRN)?
Does Newron Pharmaceuticals SpA(XSWX:NWRN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |